| | | FAMOTIDINE FOR SYSTEM SUITABILITY CAS:76824-35-6 Trade Name: 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpropanimidamide Formula: C8H15N7O2S3 APS76824356A 337.45 Pepdine, Famonerton, Restadin, Farmotex, Ulcetrax, Ulcidine, Cepal, Logos, Pepdul mite, Fibonel, Ulfamid, Famodin, Gastridin, Nevofam, Fenox, Famotin, Ganor, Weimok, Brolin, Pepcidine, Pepzan, Durater, Famogard, Pepcid PM, Muclox, 3-[(2-Dia FAMOTIDINE FORMALDEHYDE ADDUCT MALEATE (2-[4-[2-(1,1-DIOXO-3,4-DIHYDRO-2H-1,2,4,6-THIATRIAZIN-5-YL)ETHYLSULFANYLMETHYL]-1,3-THIAZOL-2-YL]GUANIDINE MALEATE) Trade Name: 2-[4-[2-(1,1-dioxo-3,4-dihydro-2H-1,2,4,6-thiatriazin-5-yl)ethylsulfanylmethyl]thiazol-2-yl]guanidin Formula: C9H15N7O2S3.C4H4O4 APS008064 465.53 Famotidine Impurity C1 as Maleate,[4-[[[2-(3,4-dihydro-1,1-dioxido-2H-1,2,4,6-thiatriazin-3-yl)ethyl]thio]methyl]-2-thiazolyl]guanidine Maleate, Famotidine Formaldehyde Adduct Maleate, 2-(4-(((2-(1,1-Dioxido-3,4-dihydro-2H-1,2,4,6-thiatriaz FAMOTIDINE RELATED COMPOUND B CAS:89268-62-2 Formula: C16H23N11O2S5 ACM89268622 561.76 3,5-Bis[2-[[[2-[(Diaminomethylene)amino]thiazol-4-yl]methyl]thio]-ethyl]-4H-1,2,4,6-thiatriazine-1,1-dioxide; N,N'''-[(1,1-Dioxido-2H-1,2,4,6-thiatriazine-3,5-diyl) bis(2,1-ethanediylthiomethylene-4,2-thiazolediyl)]bisguanidine; FAMOXADONE-D5 Trade Name: 5-methyl-3-(2,3,4,5,6-pentadeuterioanilino)-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione Formula: C22D5H13N2O4 APS001700 379.4201 DPX-JE 874-d5, 5-Methyl-5-(4-phenoxyphenyl)-3-(phenylamino)-2,4-oxazolidinedione-d5,Famoxadone D5 (Phenylamino D5), Famoxate-d5 FAP Protein, Cynomolgus, Recombinant (His & Avi), Biotinylated RHC-ENZY-1986 88 kDa (predicted). Due to glycosylation, the prot SIMP, Seprase, FAP+¦, FAPalpha, FAPA, FAP, DPPIVA, DPPIV, APCE FAP Protein, Human, Recombinant (aa 27-760, His) RHC-ENZY-1921 86.31 kDa (predicted); 82.55 kDa (reducing conditi SIMP, fibroblast activation protein, +¦, fibroblast activation protein, alpha, Fibroblast Activation Protein +¦, Fibroblast Activation Protein alpha, Fap+¦, Fapalpha, FAPA, DPPIVA, DPPIV FAP Protein, Human, Recombinant (hFc) RHC-ENZY-1342 112.3 kDa (predicted). Due to glycosylation, the p SIMP, Seprase, FAP+¦, FAPalpha, FAPA, FAP, DPPIVA, DPPIV, APCE FAP Protein, Human, Recombinant (His & Avi), Biotinylated RHC-ENZY-1397 88.23 kDa (predicted); 102.0 kDa (reducing conditi SIMP, fibroblast activation protein, +¦, fibroblast activation protein, alpha, Fibroblast Activation Protein +¦, Fibroblast Activation Protein alpha, Fap+¦, Fapalpha, FAPA, DPPIVA, DPPIV FAP Protein, Human, Recombinant (His) RHC-ENZY-1355 87.2 kDa (predicted); 90 kDa (reducing condition, SIMP, fibroblast activation protein, +¦, fibroblast activation protein, alpha, Fibroblast Activation Protein +¦, Fibroblast Activation Protein alpha, Fap+¦, Fapalpha, FAPA, DPPIVA, DPPIV FAP Protein, Human, Recombinant (His), Biotinylated RHC-ENZY-1830 87.2 kDa (predicted) SIMP, fibroblast activation protein, +¦, fibroblast activation protein, alpha, Fibroblast Activation Protein +¦, Fibroblast Activation Protein alpha, Fap+¦, Fapalpha, FAPA, DPPIVA, DPPIV FAP Protein, Mouse, Recombinant (His) RHC-ENZY-2205 86.4 kDa (predicted). Due to glycosylation, the pr SIMP, Seprase, FAP+¦, FAPalpha, FAPA, FAP, DPPIVA, DPPIV, APCE FARADIOL CAS:20554-95-4 Trade Name: (3S,4aR,6aR,6aR,6bR,8S,8aS,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,6a,7,8,9 Formula: C30H50O2 FFC-AR-20554954 442.73 (3+¦,16+¦,18+¦,19+¦)-Urs-20-ene-3,16-diol, 16+¦-Hydroxypseudotaraxasterol FARADIOL CAS:20554-95-4 Trade Name: (3S,4aR,6aR,6aR,6bR,8S,8aS,12S,12aS,14bR)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,6a,7,8,9,12,1 Formula: C30H50O2 ACM20554954 442.7 FARGESIN CAS:31008-19-2 Trade Name: 5-[(3S,3aR,6R,6aR)-6-(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-1,3-benzodi Formula: C21H22O6 BBC31008192 370.39 (1S,3a+¦,6a+¦)-1+¦-(1,3-Benzodioxole-5-yl)-4+¦-(3,4-dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan FARGESIN CAS:31008-19-2 Trade Name: 5-[(3S,3aR,6R,6aR)-6-(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-1,3-benzodi Formula: C21H22O6 ACM31008192 370.39 (1S,3a+¦,6a+¦)-1+¦-(1,3-Benzodioxole-5-yl)-4+¦-(3,4-dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan FARGESIN CAS:68296-27-5 Trade Name: 5-[(3R,3aS,6S,6aS)-6-(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-1,3-benzodi Formula: C21H22O6 FFC-AR-68296275 370.4 Planinin FARGESONE A CAS:116424-69-2 Trade Name: (2S,3R,3aR,7S,7aS)-2-(1,3-benzodioxol-5-yl)-3a,4-dimethoxy-3-methyl-7-prop-2-enyl-2,3,7,7a-tetrahydr Formula: C21H24O6 BBC116424692 372.4 [2R-(2alpha,3beta,3abeta,7alpha,7abeta)]-2-(1,3-Benzodioxol-5-yl)-3,3a,7,7a-tetrahydro-3a,4-dimethoxy-3-methyl-7-(2-propenyl)-6(2H)-benzofuranone FARGESONE A CAS:116424-69-2 Trade Name: (2S,3R,3aR,7S,7aS)-2-(1,3-benzodioxol-5-yl)-3a,4-dimethoxy-3-methyl-7-prop-2-enyl-2,3,7,7a-tetrahydr Formula: C21H24O6 ACM116424692 372.4 [2R-(2alpha,3beta,3abeta,7alpha,7abeta)]-2-(1,3-Benzodioxol-5-yl)-3,3a,7,7a-tetrahydro-3a,4-dimethoxy-3-methyl-7-(2-propenyl)-6(2H)-benzofuranone FARGESONE B CAS:116424-70-5 Trade Name: (2S,3R,3aR,7R,7aS)-2-(1,3-benzodioxol-5-yl)-3a,4-dimethoxy-3-methyl-7-prop-2-enyl-2,3,7,7a-tetrahydr Formula: C21H24O6 ACM116424705 372.4 6(2H)-Benzofuranone, 2-(1,3-benzodioxol-5-yl)-3,3a,7,7a-tetrahydro-3a,4-dimethoxy-3-methyl-7-(2-propen-1-yl)-, (2S,3R,3aR,7R,7aS)- FARGESONE B CAS:116424-70-5 Trade Name: (2S,3R,3aR,7R,7aS)-2-(1,3-benzodioxol-5-yl)-3a,4-dimethoxy-3-methyl-7-prop-2-enyl-2,3,7,7a-tetrahydr Formula: C21H24O6 BBC116424705 372.4 6(2H)-Benzofuranone, 2-(1,3-benzodioxol-5-yl)-3,3a,7,7a-tetrahydro-3a,4-dimethoxy-3-methyl-7-(2-propen-1-yl)-, (2S,3R,3aR,7R,7aS)- FARNESAL CAS:19317-11-4 Trade Name: 3,7,11-trimethyldodeca-2,6,10-trienal Formula: C15H24O FFC-AR-19317114 220.35 3,7,11-trimethyldodeca-2,6,10-trienal, 2,6,10-Dodecatrienal, 3,7,11-trimethyl-, 3,7,11-Trimethyldodeca-2,6,10-trienone FARNESYL ACETATE CAS:29548-30-9 Formula: C17H28O2 HG29548309 264.4 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, acetate;3,7,11-Trimethyldodeca-2,6,10-trienyl acetate FARNESYL ACETATE CAS:29548-30-9 Trade Name: [(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl] acetate Formula: C17H28O2 CI-GU-0121 264.4 g/mol 2,6,1-Dodecatrien-1-ol, 3,7,11-trimethyl-, acetate;3,7,11-Trimethyldodeca-2,6,1-trienyl acetate FARNESYL PYROPHOSPHATE TRIAMMONIUM SALT CAS:116057-57-9 Trade Name: phosphono [(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl] hydrogen phosphate Formula: C15H37N3O7P2 ACM116057579 433.42 Diphosphoric Acid P-[(2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-yl] Ester Ammonium Salt; (E,E)-Diphosphoric Acid Mono(3,7,11-trimethyl-2,6,10-dodecatrienyl) Ester Triammonium Salt; FARNESYL PYROPHOSPHATE-D3 TRIAMMONIUM SALT Formula: C15H34D3N3O7P2 ACMA00057331 436.44 Diphosphoric Acid P-[(2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-yl-d3] Ester Ammonium Salt; (E,E)-Diphosphoric Acid Mono(3,7,11-trimethyl-2,6,10-dodecatrienyl-d3) Ester Triammonium Salt FARNESYLACETONE CAS:1117-52-8 Trade Name: (5E,9E)-6,10,14-trimethylpentadeca-5,9,13-trien-2-one Formula: C18H30O FFC-AR-1117528 262.43 (5E,9E)-6,10,14-Trimethylpentadeca-5,9,13-trien-2-one FARNESYLACETONE CAS:1117-52-8 Trade Name: (5E,9E)-6,10,14-trimethylpentadeca-5,9,13-trien-2-one ACM1117528-1 262.4 (E,E)-6,10,14-Trimethylpentadeca-5,9,13-trien-2-one FARNESYLPYROPHOSPHATE CAS:13058-04-3 Formula: C15H37N3O7P2 ACM13058043 433.42 TRANS, TRANS FARNESYL PYROPHOSPHATE TRIAMMONIUM SALT;3,7,11-TRIMETHYL-2,6,10-DODECATRIEN-1-OL PYROPHOSPHATE;3,7,11-TRIMETHYL-2,6,10-DODECATRIEN-1-OL PYROPHOSPHATE 3NHGéâ;3,7,11-TRIMETHYL-2,6,10-DODECATRIEN-1-OL PYROPHOSPHATE AMMONIUM SALT;FAR FARREROL CAS:24211-30-0 Trade Name: (4R,5S)-4-propan-2-yl-5-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-1,3-oxazolidin-2-one Formula: C17H16O5 ACM24211300 475.245702;g/mol matteucinol; 6,8-dimethyl-5,7,4-trihydroxyflavanone; farresol; Farrerol; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-6,8-dimethylchroman-4-one; Fas Ligand Protein, Human, Recombinant (His) RHC-CD-1308 19.3 kDa (predicted); 26 kDa (reducing conditions) TNLG1A, TNFSF6, FASLG, FASL, Fas ligand, CD95-L, CD95L, CD178, APTL, APT1LG1, ALPS1B Fas Ligand Protein, Mouse, Recombinant (His) RHC-CD-1508 18.2 kDa (predicted) Tnfsf6, gld, Faslg, Fas-L, Fasl, Fas ligand, CD95-L, Cd95l, CD178, Apt1lg1 Fas/CD95 Protein, Human, Recombinant (His) RHC-CD-0019 18.2 kDa (predicted); 35 kDa (reducing condition, TNFRSF6, FASTM, FAS1, Fas cell surface death receptor, CD95, APT1, APO-1, ALPS1A Fas/CD95 Protein, Mouse, Recombinant (His) RHC-CD-0042 18 kDa (predicted); 30-35 kDa (reducing condition, Tnfrsf6, TNFR6, lpr, Fas cell surface death receptor, CD95, APT1, APO1, AI196731 Fascaplysine CAS:114719-57-2 Trade Name: 3-aza-13-Azoniapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4,6,8,11,14,16,18-nonaen-20-one ACM114719572-1 306.7 Fascaplysin chloride FASCICULATIN CAS:37905-12-7 Trade Name: (5E)-5-[(7E,9E)-13-(furan-3-yl)-2,6,10-trimethyltrideca-7,9-dienylidene]-4-hydroxy-3-methylfuran-2-o Formula: C25H34O4 ACM37905127 398.5 AC1O3M1U, 37905-12-7, NSC254239, NSC-254239, (2E)-2-[(7E,9E)-13-(furan-3-yl)-2,6,10-trimethyltrideca-7,9-dienylidene]-5-hydroxy-4-methylfuran-3-one FASENTIN CAS:392721-37-8 Trade Name: N-[4-chloro-3-(trifluoromethyl)phenyl]-3-oxobutanamide Formula: C11H9ClF3NO2 ACM392721378 279.64 Glucose Transporter Inhibitor, N-[4-chloro-3-(trifluoromethyl)phenyl]-3-oxobutanamide, ST51005182, N-(4-Chloro-3-(trifluoromethyl)phenyl)-3-oxobutanamide, Fasentin, ZINC00449608, AC1LGZUC, CBMicro_009435, AC1Q1K2J, CTK7G4986, MolPort-002-18 FAST BLUE BB CAS:120-00-3 Trade Name: N-(4-amino-2,5-diethoxyphenyl)benzamide Formula: C17H20N2O3 ACM120003 300.36 Fast Blue BB Base, Fast blue BB, Blue Salt NBB, Fast Blue BBN, Stabamine Blue BB, Blue 2B base, Fast Blue Base BB, Fast Blue EB Base, Spectrolene Blue BB, Daito Blue Base BB, Diazo Fast Blue BB, Tulabase Fast Blue BB, Naphtoelan Blue BB Bas FAST RED ITR CAS:97-35-8 Trade Name: 3-amino-N,N-diethyl-4-methoxybenzenesulfonamide Formula: C11H18N2O3S ACM97358 258.34 Red ITR base, Fast Red ITR Base, Fast Red ITR, Orle Base Fast Red ITR, Azoic Diazo No. 42, Brentamine Fast Red ITR Base, MLS000776114, Azoic diazo component 42, base, N1,N1-Diethyl-4-methoxymetanilamide, 2-Methoxy-5-(diethylsulfamoyl)anilin FATPA CAS:1131007-94-7 Formula: C63H51N ACM1131007947-1 822.09 g/mol 4,4,8,8,12,12-Hexakis(4-methylphenyl)-4H,8H,12H-benzo[1,9]quinolizino[3,4,5,6,7-defg]acridine FATTY ACIDS, C18-UNSATD, DIMERS, POLYMERS WITH BISPHENOL A, ETHYLENEDIAMINE, FORMALDEHYDE, GLYCEROL, ISOPHTHALIC ACID, LINSEED OIL, MALEIC ANHYDRIDE, ROSIN, TALL-OIL FATTY ACIDS, 1-TRIDECANOL AND TRIM CAS:68459-39-2 ACM68459392 FATTY ACIDS, TALL-OIL, POLYMERS WITH PENTAERYTHRITOL, PHTHALIC ANHYDRIDE AND ROSIN CAS:68038-31-3 ACM68038313 Fatty acids, tall-oil, polymers with pentaerythritol, phthalic anhydride and rosin;Pentaerythritol, phthalic anhydride, rosin, tall oil fatty acid polyester;Pentaerythritol, phthalic anhydride, rosin, tall oil fatty acid polymer;Rosin, tall FATTY ACIDS,TALLOW,HYDROGENATED,CALCIUM SALTS CAS:66071-81-6 Formula: C36H70CaO4 ACM66071816 607.0166 CALCIUM OCTADECANOATE;STEARIC ACID CALCIUM SALT;Fatty acids, tallow, hydrogenated, calcium salts;Fatty acids, tallow, hydrogenated, calcium salt;Fatty acids,tallow,hydrogenated,calcium salt;Hydrogenated tallow fatty acids, calcium salt;Tall FATTY ACIDS,TALLOW,HYDROGENATED,CALCIUM SALTS CAS:66071-81-6 Formula: C36H70CaO4 ACM66071816-1 607.0166 CALCIUM OCTADECANOATE;STEARIC ACID CALCIUM SALT;Fatty acids, tallow, hydrogenated, calcium salts;Fatty acids, tallow, hydrogenated, calcium salt;Fatty acids,tallow,hydrogenated,calcium salt;Hydrogenated tallow fatty acids, calcium salt;Tall FATTYACIDS, C18-UNSATD., DIMERS, DI-MEESTERS, HYDROGENATED CAS:147853-32-5 ACM147853325 Fatty acids, C18-unsatd., dimers, di-Me esters, hydrogenated;Fettsuren, C18-ungesttigt, dimerisiert, Dimethylester, hydriert;Fatty acids, unsatd(C=18)., dimers, di-Me esters, hydrogenated FATTYACIDS, RAPE-OIL, MIXED ESTERS WITH 1,4:3,6-DIANHYDRO-D-GLUCITOL, SORBITAN ANDSORBITOL CAS:93334-10-2 ACM93334102 Fatty acids, rape-oil, mixed esters with 1,4:3,6-dianhydro-d-glucitol, sorbitan and sorbitol FAZADINIUM BROMIDE CAS:49564-56-9 Trade Name: (E)-bis(3-methyl-2-phenylimidazo[1,2-a]pyridin-4-ium-1-yl)diazene dibromide Formula: C28H24N6Br2 ACM49564569 604.338360 [g/mol] Fazadinium bromide, Fazadon, Fazadinium bromide (INN), AH-8165, CID6321422, D07273, 49564-56-9, 1,1-(E)-diazene-1,2-diylbis(3-methyl-2-phenyl-1H-imidazo[1,2-a]pyridin-4-ium) dibromide Fc epsilon RI alpha/FCER1a Protein, Human, Recombinant (His) RHC-RP-1958 22.1 kDa (predicted). Due to glycosylation, the pr Fc-+¦ RI-+¦, FcERI, FCER1A, Fc-epsilon RI-+¦, Fc-epsilon RI-alpha, FCE1A, Fc +¦ RI +¦/FCER1a, Fc epsilon RI +¦/FCER1a Fc epsilon RI Protein, Human, Recombinant RHC-RP-1888 21 kDa (predicted); 42.5 kDa (reducing condition, +¦ polypeptide, FcERI, FCE1A, Fc +¦ RI, Fc fragment of IgE, high affinity I, receptor for, alpha polypeptide Fc epsilon RI Protein, Mouse, Recombinant (hFc) RHC-RP-1884 48 kDa (predicted); 63 kDa (reducing condition, du +¦ polypeptide, fc+¦ri, Fcr-5, FcERI, fcepsilonri, Fce1a, Fc +¦ RI, Fc fragment of IgE, high affinity I, receptor for, alpha polypeptide Fc gamma RIIA/CD32a (H167) Protein, Human, Recombinant (His & Avi) RHC-RP-1925 23.2 kDa (predicted). Due to glycosylation, the pr fcRII-a, FCRIIA, FcgRIIA, FCGR2A1, FCGR2A, FCGR2, FCG2, Fc +¦ RIIA, Fc gamma RIIA, CD32A Fc gamma RIIA/CD32a (H167) Protein, Human, Recombinant (His & Avi), Biotinylated RHC-RP-1901 23.2 kDa (predicted). Due to glycosylation, the pr fcRII-a, FCRIIA, FcgRIIA, FCGR2A1, FCGR2A, FCGR2, FCG2, Fc +¦ RIIA, Fc gamma RIIA, CD32A Fc gamma RIIA/CD32a (R167) Protein, Human, Recombinant (His & Avi) RHC-RP-1905 23.2 kDa (predicted). Due to glycosylation, the pr fcRII-a, FCRIIA, FcgRIIA, FCGR2A1, FCGR2A, FCGR2, FCG2, Fc +¦ RIIA, Fc gamma RIIA, CD32A Fc gamma RIIA/CD32a (R167) Protein, Human, Recombinant (His & Avi), Biotinylated RHC-RP-1927 23.2 kDa (predicted). Due to glycosylation, the pr fcRII-a, FCRIIA, FcgRIIA, FCGR2A1, FCGR2A, FCGR2, FCG2, Fc +¦ RIIA, Fc gamma RIIA, CD32A Fc gamma RIIB/CD32b Protein, Human, Recombinant (His & Avi), Biotinylated RHC-RP-1985 22.5 kDa (predicted). Due to glycosylation, the pr IGFR2, FCGR2A, FCGR21, FCGR2, FcGR, FCG2, Fc +¦ RIIB, Fc +¦ RII, Fc gamma RIIB, Fc gamma RII, CDw32, CD32b, CD32A, CD32 Fc gamma RIIIA/CD16a (F176) Protein, Human, Recombinant (His & Avi), Biotinylated RHC-RP-1989 24.7 kDa (predicted). Due to glycosylation, the pr IMD20, IGFR3, FcRIIIa, FcRIII, FcR-10, FcgRIIIA, FCGRIII, FCGR3A, FCGR3, FCG3, Fc +¦ RIIIA/CD16a (F176), Fc +¦ RIIIA, Fc gamma RIIIA, CD16A, CD16 Fc gamma RIIIA/CD16a (V176) Protein, Human, Recombinant (His & Avi), Biotinylated RHC-RP-1990 24.7 kDa (predicted). Due to glycosylation, the pr IMD20, IGFR3, FcRIIIa, FcRIII, FcR-10, FcgRIIIA, FCGRIII, FCGR3A, FCGR3, FCG3, Fc +¦ RIIIA/CD16a (V176), Fc +¦ RIIIA, Fc gamma RIIIA, CD16A, CD16 Fc gamma RIIIB/CD16b (NA2) Protein, Human, Recombinant (His & Avi) RHC-RP-1902 23.7 kDa (predicted). Due to glycosylation, the pr IGFR3, FCRIIIB, FCR-10, FcgRIIIB, FCGR3B, FCGR3, FCG3B, FCG3, Fc +¦ RIIIB/CD16b (NA2), Fc +¦ RIIIB, Fc gamma RIIIB, CD16b (NA2), CD16B, CD16 Fc gamma RIIIB/CD16b (NA2) Protein, Human, Recombinant (His & Avi), Biotinylated RHC-RP-1906 23.7 kDa (predicted). Due to glycosylation, the pr IGFR3, FCRIIIB, FCR-10, FcgRIIIB, FCGR3B, FCGR3, FCG3B, FCG3, Fc +¦ RIIIB/CD16b (NA2), Fc +¦ RIIIB, Fc gamma RIIIB, CD16b (NA2), CD16B, CD16 FCGR4 Protein, Mouse, Recombinant (His & Avi) RHC-RP-1879 24.2 kDa (predicted); 25-35 kDa (reducing conditio Fc+¦RIV, Fcrl3, FcgRIV, Fcgr3a, FcgammaRIV, Fc receptor, IgG, low affinity IV, CD16-2, 4833442P21Rik FCGR4 Protein, Mouse, Recombinant (His & Avi), Biotinylated RHC-RP-1978 24.2 kDa (predicted); 35-40 kDa (reducing conditio Fc+¦RIV, Fcrl3, FcgRIV, Fcgr3a, FcgammaRIV, Fc receptor, IgG, low affinity IV, CD16-2, 4833442P21Rik FCGR4 Protein, Mouse, Recombinant (His) RHC-RP-1929 22.4 kDa (predicted); 25-35 kDa (reducing conditio Fc+¦RIV, Fcrl3, FcgRIV, Fcgr3a, FcgammaRIV, Fc receptor, IgG, low affinity IV, CD16-2, 4833442P21Rik FCGRT & B2M Heterodimer Protein, Cynomolgus, Recombinant (His & Avi), Biotinylated RHC-RP-1983 45.3 kDa (predicted) Fc fragment of IgG, receptor, transporter, +¦, Fc fragment of IgG, receptor, transporter, alpha FCGRT & B2M Heterodimer Protein, Cynomolgus, Recombinant (His), Biotinylated RHC-RP-1931 43.5 kDa (predicted) Fc fragment of IgG, receptor, transporter, +¦, Fc fragment of IgG, receptor, transporter, alpha FCGRT & B2M Heterodimer Protein, Human, Recombinant (His & Avi) RHC-RP-1950 45.3 kDa (predicted); 36.2&12.5 kDa (reducing cond +¦-chain, FCRN, Fc fragment of IgG, receptor, transporter, +¦, Fc fragment of IgG, receptor, transporter, alpha, alpha-chain FCGRT & B2M Heterodimer Protein, Human, Recombinant (His & Avi), Biotinylated RHC-RP-1970 45.3 kDa (predicted) +¦-chain, FCRN, Fc fragment of IgG, receptor, transporter, +¦, Fc fragment of IgG, receptor, transporter, alpha, alpha-chain FCGRT & B2M Heterodimer Protein, Human, Recombinant (His) RHC-RP-1980 43.5 kDa (predicted); 35&12 kDa (reducing conditio +¦-chain, FCRN, Fc fragment of IgG, receptor, transporter, +¦, Fc fragment of IgG, receptor, transporter, alpha, alpha-chain FCGRT & B2M Heterodimer Protein, Human, Recombinant (His), Biotinylated RHC-RP-1899 43.5 kDa (predicted) +¦-chain, FCRN, Fc fragment of IgG, receptor, transporter, +¦, Fc fragment of IgG, receptor, transporter, alpha, alpha-chain FCGRT & B2M Heterodimer Protein, Mouse, Recombinant (His & Avi), Biotinylated RHC-RP-1964 46 kDa (predicted) FcRn, Fc fragment of IgG, receptor, transporter, +¦, Fc fragment of IgG, receptor, transporter, alpha FCGRT & B2M Heterodimer Protein, Mouse, Recombinant (His) RHC-RP-1862 43.5 kDa (predicted); 35&12 kDa (reducing conditio FcRn, Fc fragment of IgG, receptor, transporter, +¦, Fc fragment of IgG, receptor, transporter, alpha FCGRT & B2M Heterodimer Protein, Mouse, Recombinant (His), Biotinylated RHC-RP-1982 44.2 kDa (predicted) FcRn, Fc fragment of IgG, receptor, transporter, +¦, Fc fragment of IgG, receptor, transporter, alpha FCGRT & B2M Heterodimer Protein, Rat, Recombinant (His), Biotinylated RHC-RP-1887 44 kDa (predicted) Fc fragment of IgG, receptor, transporter, +¦, Fc fragment of IgG, receptor, transporter, alpha FcRH1/FCRL1 Protein, Mouse, Recombinant (His) RHC-CD-0260 21.6 kDa (predicted); 42-47 kDa (reducing conditio Ifgp1, Fcrh1s, Fcrh1l, Fcrh1, Fc receptor like 1, Bxmh1b, Bxmh1, Bxmas1, A230020G22Rik FcRH2/FCRL2 Protein, Human, Recombinant (His) RHC-RP-1934 42.5 kDa (predicted) SPAP1C, SPAP1B, SPAP1A, SPAP1, IRTA4, IFGP4, FCRL2, FCRH2, Fc receptor like 2, CD307b FcRH5/FcRL5 Protein (Primary Amine Labeling), Human, Recombinant (His), Biotinylated RHC-RP-1883 92.38 kDa (predicted). Due to glycosylation, the p IFGP5, FLJ00397, FLJ00333, FcR-like protein 5, FcRL5, FCRH5MGC119593, FcRH5, DKFZp667F216, DKFZp667E2019, CD307e, CD307, BXMAS1MGC119592, BXMAS1 FcRH5/FcRL5 Protein, Human, Recombinant (His & Avi), Biotinylated RHC-RP-1903 94.19 kDa (predicted). Due to glycosylation, the p IFGP5, FLJ00397, FLJ00333, FcR-like protein 5, FcRL5, FCRH5MGC119593, FcRH5, DKFZp667F216, DKFZp667E2019, CD307e, CD307, BXMAS1MGC119592, BXMAS1 FcRH5/FcRL5 Protein, Mouse, Recombinant (His) RHC-RP-1955 53.7 kDa (predicted). Due to glycosylation, the pr IFGP5, FLJ00397, FLJ00333, FcR-like protein 5, FcRL5, FCRH5MGC119593, FcRH5, DKFZp667F216, DKFZp667E2019, CD307e, CD307, BXMAS1MGC119592, BXMAS1 |